: 24161318MH  - Antineoplastic Agents/*adverse effects/therapeutic useMH  - Cardiomyopathies/chemically induced/mortality/*therapyMH  - Cause of Death/trendsMH  - FemaleMH  - Follow-Up StudiesMH  - Heart-Assist Devices/*trendsMH  - HumansMH  - MaleMH  - Middle AgedMH  - Neoplasms/drug therapyMH  - *RegistriesMH  - Retrospective StudiesMH  - Survival Rate/trendsMH  - Treatment OutcomeMH  - United States/epidemiologyOTO - NOTNLMOT  - CCMPOT  - ICMPOT  - LVADOT  - MCSOT  - NICMPOT  - RVOT  - RVADOT  - assist devicesOT  - chemotherapy-induced cardiomyopathyOT  - heart failureOT  - ischemic cardiomyopathyOT  - left ventricular assist deviceOT  - mechanical circulatory supportOT  - nonischemic cardiomyopathyOT  - right ventricularOT  - right ventricular assist deviceEDAT- 2013/10/29 06:00MHDA- 2014/03/19 06:00CRDT- 2013/10/29 06:00PHST- 2013/02/11 [received]PHST- 2013/08/30 [revised]PHST- 2013/09/11 [accepted]PHST- 2013/10/23 [aheadofprint]AID - S0735-1097(13)05588-5 [pii]AID - 10.1016/j.jacc.2013.09.040 [doi]PST - ppublishSO  - J Am Coll Cardiol. 2014 Jan 28;63(3):240-8. doi: 10.1016/j.jacc.2013.09.040. Epub      2013 Oct 23.